4//SEC Filing
Johnson Charles A 4
Accession 0001181431-10-047097
CIK 0001040416other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 11:44 AM ET
Size
8.4 KB
Accession
0001181431-10-047097
Insider Transaction Report
Form 4
Johnson Charles A
EVP of R&D & Chief Med. Ofcr.
Transactions
- Award
Restricted Stock Unit
2010-09-15−150,000→ 150,000 total→ Common Stock (150,000 underlying) - Award
Stock Option (Right to Buy)
2010-09-15−250,000→ 250,000 totalExercise: $5.11Exp: 2017-09-14→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Shall vest over 4 years as follows: 25% on the first anniversary on which the executive's employment with the Company commences, and thereafter in thirty-six (36) monthly installments after the first anniversary of the date of employment until fully vested.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the common stock of Inspire Pharmaceuticals, Inc. The shares will be delivered following the end of the scheduled vesting date or 60 days following an earlier vesting date that occurs as a result of the grantee's separation from service.
- [F3]Vests as follows: 25% percent as of the first anniversary of the effective date of the executive's employment and the remainder shall then vest ratably on an annual basis over the next three years on the respective anniversary dates of the effective date of the executive's employment until fully vested.
Documents
Issuer
INSPIRE PHARMACEUTICALS INC
CIK 0001040416
Entity typeother
Related Parties
1- filerCIK 0001500743
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 11:44 AM ET
- Size
- 8.4 KB